Back to Rounds

Series C Round

For GlycomineBio

$115.0M Apr 17, 2025
Funding Details

GlycomineBio is a biotechnology startup focused on developing replacement therapies for rare genetic diseases, specifically advancing GLM-101 into a phase IIb study in patients with PMM2CDG, a congenital disorder of glycosylation.

Confidence Score
Data extraction confidence: 90%
Participating Investors

No investors recorded for this funding round.

Related Tweets

No tweets found for this funding round.

Other Data Sources
1
Exa Round Data
Apr 21, 2025
Exa Enrichment History
1

Fields Updated
amount stage currency announced_date description
Enrichment Details
Stage
Series C
Amount
115.0
Currency
USD
Announced Date
2025-04-17T20:00:01
Description
GlycomineBio is a biotechnology startup focused on developing replacement therapies for rare genetic diseases, specifically advancing GLM-101 into a phase IIb study in patients with PMM2CDG, a congenital disorder of glycosylation.
Enrichment History
  • {'updated_at': '2025-04-24T20:45:58.794707', 'fields_updated': {'amount': True, 'stage': True, 'currency': True, 'announced_date': True, 'description': True}, 'query_used': 'GlycomineBio Series C funding round investment valuation', 'sources_count': 5}
Source URLs